NovalGen

VelaVigo

This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.

Radiant Biotherapeutics

This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.

Pandion Therapeutics

The company develops bispecific antibody therapeutics for patients with autoimmune diseases, inflammatory conditions and organ transplants to achieve localised immunomodulation.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

Candid Therapeutics

This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.

Laigo Bio

This company develops bispecific antibody therapies that remove disease-causing membrane proteins to treat patients with cancer and autoimmune disorders.

Anaveon

The company develops precision biologics and engineered antibodies to treat patients with cancer and autoimmune diseases.

Nuvig

Nuvig Therapeutics develops immunomodulatory medicines to treat patients with chronic inflammatory and autoimmune diseases.